Pluristem proposes follow-on

Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI) said late Wednesday it is planning a follow-on underwritten by Jefferies; Oppenheimer; Needham; and Maxim. ...